“…Although most authors agree that AS and tumor-related OHC constitute the best indications for ETV and are associated with the highest success rates [3,5,6,8,14,16,17,22,23,24,25,27,28,33,34,35,36,37,38], ETV is gaining more and more acceptance as an effective treatment for other forms of hydrocephalus, including those resulting from myelomeningocele [12], Chiari I malformation [9], tuberculous meningitis [19], and even idiopathic normal-pressure hydrocephalus [30] and posthemorrhagic and postinfectious hydrocephalus [18,39,40]. In addition to being an internal shunt, ETV is thought to restore the pulsatility of the ventricular walls, which results in restoration of CSF flow from the ventricular system into the subarachnoid spaces and normalization of CSF dynamics, which may account for its effectiveness in some cases of communicating hydrocephalus [25].…”